Literature DB >> 7722310

Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies.

Z E Holzknecht1, J L Platt.   

Abstract

Rejection of an organ transplanted into a phylogenetically disparate recipient may be initiated by the binding of xenoreactive natural Abs of the recipient to Ags expressed on donor endothelium leading to the activation of the C system. Having previously shown that human xenoreactive Abs bind predominantly to N-linked oligosaccharides on porcine endothelial cell glycoproteins, we sought to identify those glycoproteins to gain insight into the pathogenesis of the rejection reaction and to develop improved methods for depleting those Abs. Based on amino-terminal and internal sequencing of the glycoproteins, reactivity with monospecific rabbit Abs, and functional properties, the porcine endothelial cell targets of human natural Abs were shown to be the von Willebrand factor, integrin alpha 1, alpha v, alpha 3/alpha 5, beta 1, and beta 3 chains and a 95-kDa glycoprotein homologous with chick DM-GRASP. Human and baboon Abs directed against those glycoproteins were shown to be absorbed during perfusion of porcine organs and the binding of human IgM to the isolated glycoproteins to initiate the activation of C leading to formation of iC3b neoantigen. The determinants recognized by human xenoreactive Abs had immunodominant alpha-galactosyl residues based on affinity chromatography, reactivity with anti-Gal alpha(1-3)Gal Abs and sensitivity to alpha-galactosidase. The findings show that members of the integrin family and the von Willebrand factor are major targets of xenoreactive Abs and suggest potential mechanisms by which the binding of Abs to endothelial cells might perturb the physiology of those cells and thus cause aberrant functioning of a tissue or organ.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7722310

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Fate of antigen in xenotransplantation: implications for acute vascular rejection and accommodation.

Authors:  W Parker; Z E Holzknecht; A Song; B A Blocher; M Bustos; K J Reissner; M L Everett; J L Platt
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

Review 2.  Recent advances in the immunology of xenotransplantation.

Authors:  T Takahashi; S Saadi; J L Platt
Journal:  Immunol Res       Date:  1997       Impact factor: 2.829

3.  Specificity and function of "natural" antibodies in immunodeficient subjects: clues to B cell lineage and development.

Authors:  W Parker; P B Yu; Z E Holzknecht; K Lundberg; R H Buckley; J L Platt
Journal:  J Clin Immunol       Date:  1997-07       Impact factor: 8.317

4.  Neuronally produced versican V2 renders C-fiber nociceptors IB4 -positive.

Authors:  Oliver Bogen; Olaf Bender; Jana Löwe; Wolfgang Blenau; Beatrice Thevis; Wolfgang Schröder; Richard U Margolis; Jon D Levine; Ferdinand Hucho
Journal:  J Neurochem       Date:  2015-04-27       Impact factor: 5.372

5.  Immune complex formation after xenotransplantation : evidence of type III as well as type II immune reactions provide clues to pathophysiology.

Authors:  Z E Holzknecht; S Coombes; B A Blocher; T B Plummer; M Bustos; C L Lau; R D Davis; J L Platt
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  Interaction of baboon anti-alpha-galactosyl antibody with pig tissues.

Authors:  S Maruyama; E Cantu; C DeMartino; C Y Wang; J Chen; F Al-Mohanna; S M Nakeeb; V D'Agati; B Pernis; U Galili; G Godman; D M Stern; G Andres
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

7.  Combined transgenic expression of alpha-galactosidase and alpha1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galalpha(1,3)Gal.

Authors:  N Osman; I F McKenzie; K Ostenried; Y A Ioannou; R J Desnick; M S Sandrin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

8.  The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants.

Authors:  S S Lin; B C Weidner; G W Byrne; L E Diamond; J H Lawson; C W Hoopes; L J Daniels; C W Daggett; W Parker; R C Harland; R D Davis; R R Bollinger; J S Logan; J L Platt
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

9.  Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation.

Authors:  J C Magee; B H Collins; R C Harland; B J Lindman; R R Bollinger; M M Frank; J L Platt
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Biochemical and functional characterization of xenoreactive natural antibodies in hu-PBL-SCID mice.

Authors:  B Naziruddin; R Shiroki; S Shishido; T Howard; T Mohanakumar
Journal:  J Clin Invest       Date:  1996-03-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.